Status:
COMPLETED
HMO Research Network CERT: Acute Myocardial Infarction
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Acute Myocardial Infarction (AMI)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary goal of this study is to evaluate the effectiveness of direct-to-patient mailings designed to increase patient's adherence to prescribed beta-blockers following an acute myocardial infarct...
Detailed Description
Specific Aims: 1. Assess the persistence of beta blocker use for post-acute myocardial infarction (AMI) patients following a direct to patient intervention designed to increase rates of evidence-base...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Acute Myocardial Infarction (AMI) from 12/1/03 to 5/31/04
- Beta-blocker dispensing following AMI
- Beta-blocker dispensing prior to intervention date
Exclusion
- None
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
836 Patients enrolled
Trial Details
Trial ID
NCT00211172
Start Date
October 1 2003
End Date
May 1 2009
Last Update
October 9 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente-Georgia
Atlanta, Georgia, United States, 30305
2
Harvard Pilgrim Healthcare
Boston, Massachusetts, United States, 02115
3
Health Partners
Minneapolis, Minnesota, United States, 55440-1309
4
Kaiser Permanent Center for Health Research
Portland, Oregon, United States, 97227